Skip to content

Distal Monosomy 19p13 3 C4749277

Published: July 22, 2026Updated: August 27, 2026

A rare chromosomal deletion involving chromosome 19's short arm end, associated with developmental delays, microcephaly, and health issues. Care focuses on managing symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Cardiac anomalies

!

Epilepsy

Generalized symptoms

(congenital)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Global developmental delay

(neurological)

Microcephaly

(neurological)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Neurodevelopmental Surveillance Program

Regular neurological and developmental assessments to monitor for seizures, developmental delay, and progressive neurological complications associated with 19p13.3 microdeletions.

monitoring
2

Targeted drug therapy with dose adjustment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Motor Development Intervention

Specialized physical therapy program targeting gross motor delays, balance problems, and coordination difficulties common in distal 19p deletions.

physical_therapy

Additional treatment options

Cognitive and Behavioral Assessment Services

Comprehensive neuropsychological evaluation and ongoing support services to address learning disabilities, attention deficits, and behavioral concerns.

psychological

Symptomatic Pharmacological Management

Medication management for associated conditions such as seizures, hyperactivity, or mood disorders when these manifestations are present.

medication

Structured Family Support and Education Program

Family-centered education about the genetic condition, advocacy skills training, and connection to support resources for caregivers.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Distal Monosomy 19p13 3 C4749277?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Distal Monosomy 19p13 3 C4749277. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy